• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 DNA 结合域与其 N 端延伸的相互作用调节 p53 四聚体的稳定性。

Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.

机构信息

MRC Laboratory of Molecular Biology, Cambridge, UK.

出版信息

J Mol Biol. 2011 Jun 10;409(3):358-68. doi: 10.1016/j.jmb.2011.03.047. Epub 2011 Mar 30.

DOI:10.1016/j.jmb.2011.03.047
PMID:21457718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3176915/
Abstract

The tetrameric tumor suppressor p53 plays a pivotal role in the control of the cell cycle and provides a paradigm for an emerging class of oligomeric, multidomain proteins with structured and intrinsically disordered regions. Many of its biophysical and functional properties have been extrapolated from truncated variants, yet the exact structural and functional role of certain segments of the protein is unclear. We found from NMR and X-ray crystallography that the DNA-binding domain (DBD) of human p53, usually defined as residues 94-292, extends beyond these domain boundaries. Trp91, in the hinge region between the disordered proline-rich N-terminal domain and the DBD, folds back onto the latter and has a cation-π interaction with Arg174. These additional interactions increase the melting temperature of the DBD by up to 2 °C and inhibit aggregation of the p53 tetramer. They also modulate the dissociation of the p53 tetramer. The absence of the Trp91/Arg174 packing presumably allows nonnative DBD-DBD interactions that both nucleate aggregation and stabilize the interface. These data have important implications for studies of multidomain proteins in general, highlighting the fact that weak ordered-disordered domain interactions can modulate the properties of proteins of complex structure.

摘要

四聚体肿瘤抑制因子 p53 在细胞周期的控制中起着关键作用,并为新兴的寡聚、多结构域蛋白类提供了范例,这些蛋白具有结构和固有无序区域。其许多生物物理和功能特性都是从截短变体推断出来的,但该蛋白的某些片段的确切结构和功能作用尚不清楚。我们通过 NMR 和 X 射线晶体学发现,人 p53 的 DNA 结合域(DBD)通常定义为残基 94-292,超出了这些结构域的边界。位于无序脯氨酸丰富的 N 端结构域和 DBD 之间的铰链区域的色氨酸 91 回折到后者上,并与精氨酸 174 形成阳离子-π 相互作用。这些额外的相互作用将 DBD 的熔点提高了 2°C,抑制了 p53 四聚体的聚集。它们还调节 p53 四聚体的解离。Trp91/Arg174 包装的缺失可能允许非天然 DBD-DBD 相互作用,这些相互作用既能引发聚集,又能稳定界面。这些数据对一般的多结构域蛋白研究具有重要意义,突出了一个事实,即弱的有序-无序结构域相互作用可以调节复杂结构蛋白的性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/b764dd4bf4be/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/4d3989fb078a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/790f6ba0e18b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/8d75ed2b848b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/ddf7993002da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/0df592b5ed81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/b764dd4bf4be/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/4d3989fb078a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/790f6ba0e18b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/8d75ed2b848b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/ddf7993002da/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/0df592b5ed81/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0f/3176915/edfd463a10ee/gr6.jpg

相似文献

1
Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.p53 DNA 结合域与其 N 端延伸的相互作用调节 p53 四聚体的稳定性。
J Mol Biol. 2011 Jun 10;409(3):358-68. doi: 10.1016/j.jmb.2011.03.047. Epub 2011 Mar 30.
2
Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.四聚体 p53 的折叠:寡聚化和致瘤突变诱导错误折叠和功能丧失。
J Mol Biol. 2010 Jan 29;395(4):705-16. doi: 10.1016/j.jmb.2009.11.013. Epub 2009 Nov 11.
3
Long-range regulation of p53 DNA binding by its intrinsically disordered N-terminal transactivation domain.其无规则 N 端转录激活域对 p53 DNA 结合的远程调控。
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11302-E11310. doi: 10.1073/pnas.1814051115. Epub 2018 Nov 12.
4
A phosphorylation-dependent switch in the disordered p53 transactivation domain regulates DNA binding.磷酸化依赖的 p53 转录激活域无规则区开关调控 DNA 结合。
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1). doi: 10.1073/pnas.2021456118. Epub 2020 Dec 21.
5
The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.p53四聚体显示出其C末端结构域与DNA结合结构域之间的诱导契合相互作用。
Oncogene. 2016 Jun 23;35(25):3272-81. doi: 10.1038/onc.2015.388. Epub 2015 Oct 19.
6
The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.p53极端C末端结构域的瞬态流形结构:通过分子动力学模拟洞察无序、识别和结合多特异性
Phys Chem Chem Phys. 2017 Aug 16;19(32):21287-21296. doi: 10.1039/c7cp02485a.
7
Rational design using sequence information only produces a peptide that binds to the intrinsically disordered region of p53.仅使用序列信息进行合理设计只能产生与 p53 无规卷曲区域结合的肽。
Sci Rep. 2019 Jun 28;9(1):8584. doi: 10.1038/s41598-019-44688-0.
8
The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.与它的同源物肿瘤抑制因子p53相比,p73 DNA结合结构域表现出更高的稳定性,并呈现协同DNA结合作用。
Biochemistry. 2008 Mar 11;47(10):3235-44. doi: 10.1021/bi7023207. Epub 2008 Feb 9.
9
Alanine and proline content modulate global sensitivity to discrete perturbations in disordered proteins.丙氨酸和脯氨酸含量调节无序蛋白质对离散扰动的整体敏感性。
Proteins. 2014 Dec;82(12):3373-84. doi: 10.1002/prot.24692. Epub 2014 Oct 10.
10
Phosphorylation Regulates the Bound Structure of an Intrinsically Disordered Protein: The p53-TAZ2 Case.磷酸化调控内在无序蛋白的结合结构:以p53-TAZ2为例
PLoS One. 2016 Jan 7;11(1):e0144284. doi: 10.1371/journal.pone.0144284. eCollection 2016.

引用本文的文献

1
Pathogenic Proteins Through the Lens of NMR Spectroscopy: Structural and Functional Insights into Disease.核磁共振波谱视角下的致病蛋白:对疾病的结构与功能洞察
Cell Biochem Biophys. 2025 Aug 13. doi: 10.1007/s12013-025-01869-1.
2
DARPin-induced reactivation of p53 in HPV-positive cells.DARPin诱导人乳头瘤病毒阳性细胞中p53的重新激活。
Nat Struct Mol Biol. 2025 May;32(5):790-801. doi: 10.1038/s41594-024-01456-7. Epub 2025 Jan 9.
3
Dominant-negative mutations potentiated by the HSF1-regulated proteostasis network.由热休克因子1调节的蛋白质稳态网络增强的显性负性突变。

本文引用的文献

1
Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.突变型 p53 与多个肿瘤抑制因子共聚集获得功能。
Nat Chem Biol. 2011 May;7(5):285-95. doi: 10.1038/nchembio.546. Epub 2011 Mar 27.
2
Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA.电子显微镜研究揭示了 p53 四聚体与 DNA 复合物的不同结合模式。
Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):557-62. doi: 10.1073/pnas.1015520107. Epub 2010 Dec 22.
3
Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.
bioRxiv. 2024 Nov 3:2024.11.01.621414. doi: 10.1101/2024.11.01.621414.
4
Covalent Modification of p53 by ()-1-(4-Methylpiperazin-1-yl)-3-(5-nitrofuran-2-yl)prop-2-en-1-one.()-1-(4-甲基哌嗪-1-基)-3-(5-硝基呋喃-2-基)丙-2-烯-1-酮对p53的共价修饰
ACS Pharmacol Transl Sci. 2024 Oct 14;7(11):3559-3572. doi: 10.1021/acsptsci.4c00447. eCollection 2024 Nov 8.
5
TP53: the unluckiest of genes?TP53:最不幸的基因?
Cell Death Differ. 2025 Feb;32(2):219-224. doi: 10.1038/s41418-024-01391-6. Epub 2024 Oct 23.
6
Canonical and non-canonical functions of p53 isoforms: potentiating the complexity of tumor development and therapy resistance.p53 异构体的规范和非规范功能:增强肿瘤发展和治疗耐药性的复杂性。
Cell Death Dis. 2024 Jun 12;15(6):412. doi: 10.1038/s41419-024-06783-7.
7
Structural basis of p53 inactivation by cavity-creating cancer mutations and its implications for the development of mutant p53 reactivators.癌突变导致 p53 失活的结构基础及其对突变型 p53 复活剂开发的启示。
Cell Death Dis. 2024 Jun 11;15(6):408. doi: 10.1038/s41419-024-06739-x.
8
Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.阐明指挥链:我们目前对 p53 介导的肿瘤抑制的关键靶基因的理解。
Crit Rev Biochem Mol Biol. 2024 Feb-Apr;59(1-2):128-138. doi: 10.1080/10409238.2024.2344465. Epub 2024 Apr 25.
9
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.通过稳定剂及其类似物解决乳腺癌治疗中p53错误折叠难题:全面的计算分析
Front Pharmacol. 2024 Jan 10;14:1333447. doi: 10.3389/fphar.2023.1333447. eCollection 2023.
10
Exploring the Role of Globular Domain Locations on an Intrinsically Disordered Region of p53: A Molecular Dynamics Investigation.探讨球状结构域在 p53 无规则区域的作用:分子动力学研究。
J Chem Theory Comput. 2024 Feb 13;20(3):1423-1433. doi: 10.1021/acs.jctc.3c00971. Epub 2024 Jan 17.
单分子技术解析肿瘤抑制因子 p53 寡聚化动力学和平衡。
Nucleic Acids Res. 2011 Mar;39(6):2294-303. doi: 10.1093/nar/gkq800. Epub 2010 Nov 18.
4
The tumor suppressor p53: from structures to drug discovery.肿瘤抑制因子 p53:从结构到药物发现。
Cold Spring Harb Perspect Biol. 2010 Jun;2(6):a000919. doi: 10.1101/cshperspect.a000919. Epub 2010 Feb 10.
5
Features and development of Coot.Coot的特点与发展
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. doi: 10.1107/S0907444910007493. Epub 2010 Mar 24.
6
Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs.p53 与 Hoogsteen 碱基对形成的晶体结构揭示了 DNA 识别的多样性。
Nat Struct Mol Biol. 2010 Apr;17(4):423-9. doi: 10.1038/nsmb.1800. Epub 2010 Apr 4.
7
Structure of the p53 C-terminus bound to 14-3-3: implications for stabilization of the p53 tetramer.p53 C 端与 14-3-3 结合的结构:对 p53 四聚体稳定的影响。
FEBS Lett. 2010 Apr 16;584(8):1443-8. doi: 10.1016/j.febslet.2010.02.065. Epub 2010 Mar 3.
8
Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.p53 核心结构域与全共识序列结合形成自组装四聚体的晶体结构。
Structure. 2010 Feb 10;18(2):246-56. doi: 10.1016/j.str.2009.11.011.
9
Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.迈向p53稳定药物的合理设计:探究致癌性Y220C突变体的表面
Chem Biol. 2010 Jan 29;17(1):46-56. doi: 10.1016/j.chembiol.2009.12.011.
10
Conservation of DNA-binding specificity and oligomerisation properties within the p53 family.p53 家族中 DNA 结合特异性和寡聚化性质的保守性。
BMC Genomics. 2009 Dec 23;10:628. doi: 10.1186/1471-2164-10-628.